Strong recovery, high-margin portfolio shift, and capacity-led earnings leverage underpin ₹1,955 target ICICI Securities has reaffirmed BUY rating on Tatva Chintan Pharma with a revised target price of INR 1,955 per share, up from INR …

Strong recovery, high-margin portfolio shift, and capacity-led earnings leverage underpin ₹1,955 target ICICI Securities has reaffirmed BUY rating on Tatva Chintan Pharma with a revised target price of INR 1,955 per share, up from INR …

Bombay Coated and Special Steels (BCSSL), a growing player in India’s value-added steel processing segment, has refiled its DRHP with the Securities and Exchange Board of India (SEBI) to raise INR 191 crore via an …

Bombay Coated and Special Steels (BCSSL), a growing player in India’s value-added steel processing segment, has refiled its DRHP with the Securities and Exchange Board of India (SEBI) to raise INR 191 crore via an …

As Budget 2026 draws closer, industry leaders across sectors are pinning high hopes on it. Business heads and experts are looking for fresh reforms and targeted policy measures that can accelerate growth, improve affordability and …

When IPO frenzy meets reality: these were heavily chased, many were oversubscribed, and within a year several are available well below issue price. In primary markets, IPO demand is always loud. Oversubscription numbers get quoted …